United States · Investor

Tekla Capital Management

Last cheque observed Nov 2019. Silence since then is not evidence of inactivity: our sources miss unannounced rounds.

QuietVC firm

SeedSeries ASeries BMedical DeviceIvdIn Vitro Diagnostics

Cheques on record
0%of best year0cheques in 12 months, 10 on record
Since the last cheque2545days00hrs00min00sec
Median round$53MRounds led0 of 10Mostly inUnited States, 90%
Pitch Tekla Capital Management

Tekla Capital Management highlights

  1. 01

    10 rounds on record

  2. 02

    Mostly Series C and Growth: 70% of its rounds

What they do

Type
VC firm (from a list, unverified)
Cheque size
Not stated
Stages
SeedSeries ASeries BGrowth
Sectors
Medical DeviceIvdIn Vitro Diagnostics
Based in
United States
Cold pitches
Not stated

The record

Every round we can evidence, newest first10 appearances

  1. 2019

    2 rounds

  2. Nov
    ArkudaSeries A · US · FinSMEs$44MWith 3 others
  3. Sept
    AmphivenaSeries C · US · FinSMEs$62MWith 10 others
  4. 2015

    5 rounds

  5. Aug
    Ovid TherapeuticsSeries B · US$75MWith 7 others
  6. Jul
    Afferent PharmaceuticalsSeries C · US$55MWith 5 others
  7. Jun
    CytomX TherapeuticsSeries D · US$70MWith 8 others
  8. Apr
    MerusSeries C · NL$79MWith 10 others
  9. Mar
    VenitiSeries C · US$17MWith 1 other
  10. 2013

    1 round

  11. Oct
    Insightra MedicalSeries C · US · finsmes.comUndisclosedWith 1 other
  12. 2012

    1 round

  13. Sept
    IlluminOss MedicalSeries C · US · marketwire.com$28MWith 8 others
  14. 2006

    1 round

  15. Nov
    Magellan DiagnosticsGrowth · US$50MWith 6 others

An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.

The team

We hold 3 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.

Who they invest alongside

The investors most often in the same rounds as Tekla Capital Management. A count of rooms they were both in, not a relationship either has claimed.

Redmile GroupVC firm3rounds togetherCormorant Asset ManagementPrivate equity2rounds togetherFidelity Management and Research CompanyGrowth equity2rounds togetherJennison AssociatesGrowth equity2rounds togetherNew Leaf Venture PartnersVC firm2rounds togetherPfizerCorporate VC2rounds together

Quick answers about Tekla Capital Management

What does Tekla Capital Management invest in?

Tekla Capital Management invests most often at Series C and Growth (70% of the rounds on record), in sectors such as Medical Device, Ivd and In Vitro Diagnostics.

How active is Tekla Capital Management?

10 investments on record, 0 of them in the last 12 months. The most recent was in Nov 2019.

What has Tekla Capital Management invested in recently?

Its most recent investments on record: Arkuda (Series A, Nov 2019) and Amphivena (Series C, Sept 2019).

How big are Tekla Capital Management's cheques?

The median round it joins is $53M.

Does Tekla Capital Management lead rounds?

Rarely, if at all: none of its 10 investments on record names it as the lead.

Where does Tekla Capital Management invest?

Most of the companies it backs are in the United States (90%) and the Netherlands (10%).

Is Tekla Capital Management investing now?

No investments in the last 12 months; the latest was in Nov 2019.

Who does Tekla Capital Management invest alongside?

Most often Redmile Group (3 rounds together), Cormorant Asset Management (2 rounds together) and Fidelity Management and Research Company (2 rounds together).

Raising now?

Find the investors who back rounds like yours, and keep every conversation on one fundraising board.

Find similar investorsOpen your CRM

Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it